Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

13 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cancer-associated fibroblast transfected with miR-155, anti-miR-31 and anti-miR-214

ABSTRACT: This SuperSeries is composed of the following subset Series: GSE35249: aNOF vs. CAF GSE35250: NOF vs. coCAF 7d GSE35251: NOF vs. iCAF 2d GSE35252: NOF vs. iCAF 4d Refer to individual Series

ORGANISM(S): Homo sapiens

SUBMITTER: Youjia Hua

PROVIDER: E-GEOD-35364 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

NOF vs. coCAF 7d

Project description:Campare the difference between pairwise NOF and coCAF tissues for three patients patient #603: NOF #603 vs coCAF #603 patient #609: NOF #609 vs coCAF #609 patient #612: NOF #612 vs coCAF #612

2012-01-27 | E-GEOD-35250 | biostudies-arrayexpress

NOF vs. iCAF 2d

Project description:Compare the difference between pairwise NOF and iCAF (2d) tissues for one patient patient #474: NOF #474 vs iCAF #474

2012-01-27 | E-GEOD-35251 | biostudies-arrayexpress

NOF vs. iCAF 4d

Project description:Compare the difference between pairwise NOF and iCAF (4d) tissues for one patient patient #626: NOF #626 vs iCAF #626

2012-01-27 | E-GEOD-35252 | biostudies-arrayexpress

Cancer-associated fibroblast transfected with miR-155, anti-miR-31 and anti-miR-214

Project description:This SuperSeries is composed of the SubSeries listed below.

2012-01-27 | GSE35364 | GEO

Gene expression in kidney following UUO +/- anti-miR-214

Project description:Animals were sc dosed with 5mg/kg anti-miR-214 or control anti-miR, had UUO performed and were sacrificed at 7 days. n=4 animals per group, 2 groups

2013-11-05 | E-GEOD-48194 | biostudies-arrayexpress

PETACC-8 miR-31-3p and miR-31-5p Ancillary Study

Project description:This is a prospective-retrospective study to determine if the expression of the miRNA’s miR-31-3p and miR-31-5p are prognostic of patient outcomes or predictive of the benefit from anti-EGFR therapy in stage III Colon Cancer. The present study will utilize FFPE tumor samples collected from patients enrolled in the PETACC-8 study conducted by the Fédération Francophone de Cancérologie Digestive (FFCD). This phase 3 clinical trial prospectively randomized fully resected stage III colon cancer patients to receive adjuvant treatment with either FOLFOX-4 plus cetuximab or FLOFOX-4 alone.

| 2260465 | ecrin-mdr-crc

Homo sapiens

Project description:NOF vs. coCAF 7d

| PRJNA156037 | ENA

Homo sapiens

Project description:NOF vs. iCAF 4d

| PRJNA156041 | ENA

Homo sapiens

Project description:NOF vs. iCAF 2d

| PRJNA156039 | ENA

aNOF vs. CAF

Project description:Compare the difference between pairwise aNOF and CAF samples for two patients patient #225: aNOF #225 vs CAF #225 patient #248: aNOF #248 vs CAF #248

2012-01-27 | E-GEOD-35249 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data